Cargando…
Safety and Efficacy of Neoadjuvant Chemoimmunotherapy in Gastric Cancer Patients with a PD-L1 Positive Status: A Case Report
Introduction: The landscape of gastric cancer treatment has changed owing to the widespread use of immune checkpoint inhibitors. Autophagy, involved in regulating the immune system, is a potential trigger of immunity in tumors. This study aims to find molecular-based evidence for the effectiveness o...
Autores principales: | Avgustinovich, Alexandra V., Bakina, Olga V., Afanas’ev, Sergey G., Spirina, Liudmila V., Volkov, Alexander M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529065/ https://www.ncbi.nlm.nih.gov/pubmed/37754265 http://dx.doi.org/10.3390/cimb45090481 |
Ejemplares similares
-
LC3B, mTOR, AMPK Are Molecular Targets for Neoadjuvant Chemotherapy in Gastric Cancers
por: Spirina, Liudmila V., et al.
Publicado: (2022) -
PD-L1 Status in Gastric Cancers, Association with the Transcriptional, Growth Factors, AKT/mTOR Components Change, and Autophagy Initiation
por: Spirina, Liudmila, et al.
Publicado: (2021) -
Reactive oxygen species and age-related genes p66Shc, sirtuin, FoxO3 and klotho in senescence
por: Afanas'ev, Igor
Publicado: (2010) -
Signaling of Reactive Oxygen and Nitrogen Species in Diabetes Mellitus
por: Afanas'ev, Igor
Publicado: (2010) -
ROS and RNS Signaling in Heart Disorders: Could Antioxidant Treatment Be Successful?
por: Afanas'ev, Igor
Publicado: (2011)